Eosinophilia: Difference between revisions

 
(4 intermediate revisions by 2 users not shown)
Line 6: Line 6:


==Differential Diagnosis==
==Differential Diagnosis==
*[[Allergic reaction]] or other hypsersensitivity/atopic state
*[[Allergic reaction]] or other hypersensitivity/atopic state
**[[Urticaria]], [[atopic dermatitis]], [[asthma]], drug reaction/hypersensitivity
**[[Urticaria]], [[atopic dermatitis]], [[asthma]], drug reaction/hypersensitivity
*[[DRESS syndrome]]
*[[DRESS syndrome]], drug-induced
*[[Parasitic infection]]
*[[Parasitic infection]]
*[[Coccidioidomycosis]] and other fungal infections
*[[Coccidioidomycosis]] and other [[fungal infections]]
*Malignancy (e.g. [[lymphoma]], eosinophilic [[leukemia]])
*Malignancy (e.g. [[lymphoma]], eosinophilic [[leukemia]])
*Skin disorders (e.g. [[bullous pemphigoid]], dermatitis herpetiformis)
*Skin disorders (e.g. [[bullous pemphigoid]], dermatitis herpetiformis)
*[[Adrenal insufficiency]]
*[[Adrenal insufficiency]]
*Connective tissue disease (e.g. [[Churg-Strauss syndrome]])
*[[Connective tissue disease]] (e.g. [[Churg-Strauss syndrome]])
*Interstitial nephritis
*Interstitial nephritis
*[[Arsenic]]
*[[Arsenic]], [[gold toxicity]]


==Evaluation==
==Evaluation==
*CBC with differential


==Management==
==Management==
*Directed at underlying cause


==Disposition==
==Disposition==

Latest revision as of 17:04, 12 January 2022

Background

  • Defined usually as peripheral eosinophil count >0.5 x 109/L
  • Eosinophils normally comprise <7% of total WBC count

Clinical Features

Differential Diagnosis

Evaluation

  • CBC with differential

Management

  • Directed at underlying cause

Disposition

See Also

External Links

References